In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...
When I look back on my journey, I’m reminded of how much can change when you are able to ask for, and receive, help. My name is Dr. Christopher Schenewerk. I am a physician, a father, and a ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...
While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions.
A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...
Insurers of qualified health plans on HealthCare.gov denied about one in five in-network claims and 37% of out-of-network claims in 2023, according to a new analysis from KFF. KFF is a nonprofit ...
Breakthroughs in physics have reshaped everything from communications to consumer electronics. Yet these methods remain rare in medical practice, where healthcare costs continue to climb, and ...
Health data is a prime target of hackers given the value of healthcare data – in fact it is considered many times more valuable than financial data. Now, IEEE Standards Association has published ...